GlassScriptPhysician profile
Maria V Pucevich
NPI 1568451821
$8,093.17
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,484 · 2020: $1,500 · 2021: $2,244 · 2022: $866.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,466.89 | 2019-2022 | |
| Janssen Biotech, INC. | $1,027.85 | 2019-2022 | |
| Amgen INC. | $724.91 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $689.69 | 2019-2021 | |
| Lilly USA, LLC | $618.13 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $414.70 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $395.39 | 2019-2022 | |
| Journey Medical Corporation | $360.08 | 2019 | |
| Celgene Corporation | $301.90 | 2019 | |
| Genzyme Corporation | $272.58 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $207.84 | 2019-2021 | |
| Pfizer INC. | $204.19 | 2019-2021 | |
| Prugen, INC. Pharmaceuticals | $179.81 | 2019 | |
| Incyte Corporation | $163.62 | 2021-2022 | |
| Leo Pharma INC. | $124.31 | 2020-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $104.06 | 2019-2022 | |
| Galderma Laboratories, L.P. | $98.54 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $97.89 | 2022 | |
| Mallinckrodt Enterprises LLC | $92.00 | 2019 | |
| Glaxosmithkline, LLC. | $90.11 | 2020-2021 | |
| Biofrontera INC. | $89.89 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $70.42 | 2020-2021 | |
| Vyne Pharmaceuticals INC. | $61.35 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $53.17 | 2020 | |
| Genentech USA, INC. | $52.29 | 2019-2022 | |
| Encore Dermatology INC. | $29.43 | 2019 | |
| Mayne Pharma Commercial LLC | $24.80 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.41 | 2019 | |
| Biotissue Holdings INC. | $15.25 | 2021 | |
| Aclaris Therapeutics, INC. | $13.91 | 2019 | |
| Stemline Therapeutics INC. | $13.35 | 2021 | |
| Almirall LLC | $12.41 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Pucevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.